ciglitazone has been researched along with Dermatitis, Irritant in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Dermatitis, Irritant: A non-allergic contact dermatitis caused by prolonged exposure to irritants and not explained by delayed hypersensitivity mechanisms.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mao-Qiang, M | 1 |
Fowler, AJ | 1 |
Schmuth, M | 1 |
Lau, P | 1 |
Chang, S | 1 |
Brown, BE | 1 |
Moser, AH | 1 |
Michalik, L | 1 |
Desvergne, B | 1 |
Wahli, W | 1 |
Li, M | 1 |
Metzger, D | 1 |
Chambon, PH | 1 |
Elias, PM | 1 |
Feingold, KR | 1 |
1 other study available for ciglitazone and Dermatitis, Irritant
Article | Year |
---|---|
Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation.
Topics: Animals; Cell Differentiation; Dermatitis, Irritant; Epidermis; Female; Filaggrin Proteins; Homeosta | 2004 |